Terumo Americas Holding, the U.S. subsidiary of Japan’s Terumo Corp., acquired Onset Medical Corp., makers of access sheath technology for multiple minimally invasive applications.
Terumo is a $4 billion a year company with sales and operations in more than 160 countries, according to a press release. The value of the acquisition wasn’t made public.
Irvine, Calif.-based Onset develops access sheaths with what it calls the smallest profiles and largest internal diameters to protect against unnecessary trauma to a patient, according to a press release.
Onset’s balloon expandable catheters technology allows Terumo to penetrate the structural heart and aneurysmal repair markets, and Terumo customers will get access to the entirely of Onset’s product lines, according to the release.
With its proprietary "controlled deployment technology," Onset’s access sheaths will complement Terumo’s site management and lesion access portfolio.
"CDT literally changes the way physicians enter the vascular system and manage the access site, while allowing them to achieve easier, safer access to the target lesion in a variety of clinical applications," James Rushworth, Terumo senior VP and general manager and Onset president, said in prepared remarks. "This strategic acquisition reinforces our commitment to pursuing unique technologies that meet the specialized needs of our customers and contribute to better outcomes for their patients."
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
Fujifilm first announced the deal last month, offering $54 per share, or roughly $995 million, for the Bothell, Wash. company.
SonoSite will operate as a wholly-owned subsidiary from its Bothell, Wash., headquarters and retain its management team, according to the release. Read more